MONTREAL, Feb. 14, 2014 /CNW Telbec/ - In support of Montreal's
excellence, Pharmascience is teaming up with the Montreal Heart
Institute (MHI), the Government of Quebec and other partners as part of
the ARTERIA project, to be announced today in the presence of Quebec
Premier Pauline Marois. By joining forces we can, together, help fight
cardiovascular disease, which is the main cause of death and
hospitalization throughout the world, and affects 1.3 million
Pharmascience Chief Executive Officer David Goodman stated: "We are
proud to partner with the Montreal Heart Institute, a flagship of
excellence, and to endorse ARTERIA in a project distinguished by its
scientific and human goals. For Pharmascience, this is also an
opportunity to once again demonstrate how we tangibly contribute to
research, through our innovative use of generic drugs and by developing
"We are confident that ARTERIA will ultimately make it possible to
minimize cardiac complications, including CVAs," said Dr. Jean-Claude
Tardif, Director of the MHI Research Centre. "This unique project will
also benefit patients tremendously by transforming the medical
practices used in treating cardiovascular disease. In addition, these
evolved practices will inevitably save money for the health system.
This is why we are delighted to be able to count on support from
partners such as Pharmascience," concluded Dr. Tardif.
Thanks to the ARTERIA partnership, the Montreal Heart Institute will be
able to offer its patients diagnoses and clinical treatment using a
"personalized medicine" approach. Based on the patient's genetic
profile, this approach will allow for a customized protocol and
improved follow-up, all at a lower cost. As well, the research program
will optimize knowledge transfer among professionals, scientists and
researchers, within the Institute and with its partners.
In addition to supplying the drugs and placebos, Pharmascience will
share its expertise with the MHI, as several of its scientists will be
working with the various committees in a collective effort to find new
paths to discovery and innovation.
About Pharmascience Inc.
Founded in 1983, Pharmascience is the only Quebec-owned multinational
pharmaceutical company and the largest in the industry in Quebec, with
over 1,400 employees. For more information, visit www.pharmascience.com.
SOURCE: Pharmascience Inc.
For further information:
Dr. Didier Reymond
Senior Director, Medical Affairs
Tel.: 514 340-7840